Osteoporosis in males- references
Recent references have not been added yet
Kelepouris, N.(1995). Severe osteoporosis in men. Ann Intern Med 123: 452-460.
Bendavid, E. J.(1996). Factors associated with bone mineral density in middle-aged men. J Bone Miner Res 11: 1185-90.
Glynn, N. W.(1995). Determinants of bone mineral density in older men. J Bone Miner Res 10: 1769-1777.
Grisso, J. A.(1991). Risk factors for hip fractures in men: A preliminary study. J Bone Miner Res 6: 865-868.
Poor, G.(1995). Predictors of hip fractures in elderly men. J Bone Miner Res 10: 1900-1907.
Boonen, S.(1997). Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res 12(12): 2119-26.
Kenny, A. M.(1998). Bone density, bone turnover, and hormone levels in men over age 75. J Gerontol A Biol Sci Med Sci 53(6): M419-25.
Ongphiphadhanakul, B.(1995). Serum testosterone and its relation to bone mineral density and body composition in normal males. Clin Endocrinol (Oxf) 43(6): 727-33.
Murphy, S.(1993). Sex hormones and bone mineral density in elderly men. Bone Miner 20(2): 133-40.
Fitzgerald, R. C.(1997). Testosterone concentrations in men on chronic glucocorticosteroid therapy. J R Coll Physicians Lond 31(2): 168-70.
Nyquist, F.(1998). Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: a prospective population-based study. Bone 22(2): 147-51.
Guo, C. Y.(1997). Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 82(2): 658-65.
Kubler, A.(1992). The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome. Exp Clin Endocrinol 100(3): 129-32.
Greenspan, S. L.(1989). Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110(7): 526-31.
Finkelstein, J. S.(1987). Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106(3): 354-61.
Francis, R. M.(1986). Osteoporosis in hypogonadal men: role of decreased plasma 1,25- dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 7(4): 261-8.
Jackson, J. A.(1987). Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 65: 53-58.
Leifke, E.(1998). Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 138(1): 51-8.
Behre, H. M.(1997). Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82(8): 2386-90.
Reid, I. R. (1996). Testosterone therapy in glucocorticoid-treated men [see comments]. Arch Intern Med 156(11): 1173-7.
Anderson, F. H. (1996). Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone 18(2): 171-7.
Katznelson, L.(1996). Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81(12): 4358-65.
Hall, G. M.(1996). A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol 35(6): 568-73.
Isaia, G.(1992). Effect of testosterone on bone in hypogonadal males. Maturitas 15(1): 47-51.
Devogelaer, J. P.(1992). Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas 15(1): 17-23.
Finkelstein, J. S.(1989). Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69(4): 776-83.
Sih, R.(1997). Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 82: 1661-1667.
Bhasin, S.(1997). Emerging issues in androgen replacement therapy. J Clin Endocrinol Metab 82: 3-8.
 
Updated 10/15/04